# The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy

> **NCT01248000** · — · COMPLETED · sponsor: **Gruppo Italiano Studio Linfomi** · enrollment: 136 (actual)

## Conditions studied

- Histologically Confirmed Classical Hodgkin Lymphoma According to the Current World Health Organisation Classification

## Interventions

- **PROCEDURE:** FDG-PET

## Key facts

- **NCT ID:** NCT01248000
- **Lead sponsor:** Gruppo Italiano Studio Linfomi
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** —
- **Final completion:** 2010-05
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2010-11-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01248000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01248000, "The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01248000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*